Koninklijke Philips (NYSE:PHG) Receives Consensus Rating of “Hold” from Brokerages

Koninklijke Philips (NYSE:PHG) has received a consensus rating of “Hold” from the five research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company.

A number of equities analysts have recently commented on PHG shares. Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. StockNews.com downgraded Koninklijke Philips from a “buy” rating to a “hold” rating in a research report on Thursday, November 14th.

Koninklijke Philips Price Performance

NYSE PHG opened at $25.48 on Wednesday. Koninklijke Philips has a 1 year low of $19.55 and a 1 year high of $32.91. The company has a fifty day simple moving average of $27.30 and a 200 day simple moving average of $28.14. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60. The company has a market cap of $23.95 billion, a P/E ratio of -60.67, a P/E/G ratio of 0.92 and a beta of 0.76.

Institutional Investors Weigh In On Koninklijke Philips

A number of institutional investors have recently added to or reduced their stakes in the company. Fairscale Capital LLC bought a new stake in shares of Koninklijke Philips in the 2nd quarter worth approximately $54,000. Wilmington Savings Fund Society FSB acquired a new stake in Koninklijke Philips during the third quarter worth $54,000. Eastern Bank acquired a new stake in Koninklijke Philips during the third quarter worth $88,000. Blue Trust Inc. increased its holdings in Koninklijke Philips by 902.7% in the 2nd quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock valued at $93,000 after buying an additional 3,331 shares during the period. Finally, RPg Family Wealth Advisory LLC acquired a new position in shares of Koninklijke Philips in the 3rd quarter valued at $107,000. 13.67% of the stock is owned by institutional investors and hedge funds.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.